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 Introduction 
Rhus coriaria Linn. (family: Anacardiacea), commonly 
known as Sumac, is a perennial bushy shrub of about 3 
meter height, growing wild in Mediterranean areas, 
North Africa, Middle East, Iran and Afghanistan 
(Özcan and Haciseferogullari, 2004). The leaves being 
rich in tannins were used in dying and tanning of 
leather. The red colored fruits are used as condiment 
and are major ingredient of Zatar, a popular Arabic 
spice mixture. The fruits have also been employed 
traditionally to manage diarrhea, dysentery, sore 
throat and toothaches (Usmanghani et al., 1997; Lev 
and Amar, 2002; Shabbir, 2012). 
Phytochemical investigations on R. coriaria reported 
presence of ellagic acid, gallic acid, tannic acid, 
avicularin, myricetin, myricitrin, isoquercetin, quercetin 
and quercetrin as plant constituents (Duke, 2003; 
Mehrdad et al., 2009; Shabbir, 2012). 
Studies on R. coriaria documented antibacterial (Abbas 
and Halkman, 2004; Shanab et al., 2005), hypoglycemic 
(Giancarlo et al., 2006), antioxidant (Özcan, 2003; 
Candan and Sokmen, 2004), xanthine oxidase inhibitor 
(Candan, 2003), antimigratory (Zargham and Zarg-
ham, 2008), and DNA protective properties (Chakra-
borty et al., 2009), while its other actions have also been 
summarized in a recent review (Shabbir, 2012). The 
present study was undertaken in an attempt to validate 
traditional antidiarrheal use of R. coriaria fruits. 
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Abstract 
This study was aimed at providing the pharmacological basis for the 
medicinal use of Rhus coriaria in diarrhea. In mice, the crude of R. coriaria 
demonstrated antisecretory and antidiarrheal effects against castor oil-induced 
fluid accumulation and diarrhea at at 100 and 300 mg/kg, respectively, and 
was found safe up to tested dose of 5 g/kg. In isolated rabbit jejunum, R. 
coriaria exhibited concentration-dependent (0.01-3.0 mg/mL) relaxation of 
spontaneous and high K+ (80 mM)-induced contractions, similar to verapamil. 
The Ca++ antagonist activity was confirmed when pretreatment of R. coriaria 
shifted Ca++ concentration-response curves to the right with suppression of 
maximal response, similar to verapamil. R. coriaria also suppressed the high K+
-evoked transient contractile peaks similar to the effect of cyclopiazonic acid 
and verapamil. This study indicates that R. coriaria possesses antisecretory, 
antidiarrheal and antispasmodic properties mediated possibly through Ca++ 
antagonist pathway, thus providing evidence to its medicinal use in diarrhea 
and abdominal spasm.   
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 Materials and Methods 
Plant material and preparation of the crude extract: The 
dried fruits of R. coriaria were purchased from a local 
herbal store in Multan and authenticated by a taxo-
nomist. A specimen, voucher # RC-F-06-08-100, was 
preserved in the herbarium of the Natural Product 
Research Division, Department of Biological and 
Biomedical Sciences, the Aga Khan University, 
Karachi. The plant material was rendered free of adul-
terants and was grinded into coarse powder. The 
powdered material (1 kg) was soaked in 80% metha-
nol for 1 week with twice a day shaking. The material 
was passed through muslin cloth to remove vegetative 
debris and the obtained fluid was subsequently filtered 
through Whatman No. 1 filter paper. The filtrate was 
evaporated under reduced pressure at 35ºC on a rotary 
evaporator (Buchii model RE-111, Switzerland) to a 
thick paste (Shah et al., 2011), which was subsequently 
lyophilized to dry powder on a freeze dryer (Alpha 1-4 
LD, Christ, Germany) with approximate yield of 6%. 
The crude methanolic extract of R. coriaria (RCE) was 
found soluble in distilled water/saline for in vivo and 
in vitro experiments and all dilutions were made 
fresh on the day of experiment. 
Chemicals: Acetylcholine chloride, atropine sulphate, 
loperamide, potassium chloride verapamil hydrochlo-
ride, calcium chloride, glucose, magnesium chloride, 
sodium chloride, ethylenediamine-tetraacetic acid 
(EDTA), aluminum chloride, ammonium hydroxide, 
dragendorff's reagent and ferric chloride were 
purchased from Sigma-Aldrich Chemicals Company, St 
Louis, MO, USA. Sodium bicarbonate, sodium 
dihydrogen phosphate, methanol, benzene, chloroform, 
hydrochloric acid and petroleum ether were obtained 
from E. Merck KGa (Darmstadt, Germany). The castor 
oil was purchased from Karachi Chemical Industries 
(Pvt.) Ltd., Karachi (Pakistan).All the chemicals used 
were of analytical reagent grade and dissolved in 
distilled water/saline for in vivo and in vitro 
experiments. 
Animals: The adult (male or female) BALB/c mice (20–
25 g) and local breed rabbit (1-1.5 kg) were housed at 
the Animal House of The Aga Khan University, 
Karachi , in their respective cages lined with sawdust 
(renewed after every 48 hours), maintained at 23-25ºC, 
humidity 60% ± 4%, 12/12 hours light and dark cycles. 
Animals were provided ad libitum with tap water and 
standard diet consisting of (g/kg): flour (380), fiber 
(380), molasses (12), sodium chloride (5.80, nutrivet L 
(2.5), potassium metabisulphate (1.2), vegetable oil (38), 
fish meal (170) and powdered milk (150). The animals 
were subjected to 12-16 hours starvation prior to the 
day of experiment but had free access to water. Experi-
ments performed were complied with the rulings of the 
Institute of Laboratory Animal Resources, Commission 
on Life Sciences, National Research Council, 1996 
(National Research Council, 1996).  
Intestinal fluid accumulation assay: By following an 
earlier method (Mehmood and Gilani, 2010), overnight 
fasted mice (weighing 20-25 g, n=30) of both sexes were 
housed in cages in five equally divided groups (n=6). 
The first two groups received saline in a solubilizing 
vehicle (10 mL/kg, p.o.) and acted as negative controls. 
The animals in group three was administered 
verapamil (100 mg/kg) intraperitoneally using a 
detachable U-100 insulin syringe with a 25G × 1″ (0.50 
× 25 mm) needle, as positive control. The fourth and 
fifth groups were treated with increasing doses of the 
plant extract (100 and 300 mg/kg, i.p). One hour after 
the treatment, each animal received castor oil (10 mL/
kg) orally, except the animals in group one. All the 
animals were sacrificed 30 min later by cervical 
dislocation and the intestine was dissected out 
carefully, not allowing any intestinal fluid to leak out, 
and weighed. The results were expressed as (Pi/Pm) 
×1000 whereas, Pi is the weight of the intestine and Pm 
is the weight (in g) of the animal.   
Antidiarrheal activity: The antidiarrheal activity of RCE 
was assessed by slight modifications of a previously 
described method (Shah et al., 2011A). Twenty mice (20
-25 g) were divided into 4 groups and each group was 
containing 5 animals. The animals were housed in 
individual cages and were subjected to 12-16 hours 
fasting prior to start of experiment. The group 1st 
animals were taken as negative control to which normal 
saline (10 mL/kg) was administered orally and 
followed after 1 hour by an oral dose of castor oil (10 
mL/kg). The group 2nd animals were regarded as 
positive control and treated similar to group 1st animals 
except oral dose of loperamide (10 mg/kg) was 
substituted for normal saline. The group 3rd and 4th 
animals were treated similar to group 1st except crude 
extract at respective oral doses of 100 and 300 mg/kg 
was substituted for normal saline. After 4 hours the 
mouse cages were individually inspected for the 
presence of diarrheal wet feces and percentage decrease 
in the wet feces output as compared to the castor oil 
treated group was used to assess antidiarrheal effect. 
While counting the number of wet and dry feces, the 
dry feces was counted one in number when its size was 
found in between the range of an average size of a dry 
feces (1.3 ± 0.6 cm, width 0.4 ± 0.3 cm, n=20). Similarly 
to count wet feces, the average size was considered as, 
the length 2 ± 1.4 cm and width 1 ± 0.7 cm, n=20, with 
the exception of making decisions on the basis of our 
observational experience when there are discrepancies 
like, an irregular liquid left circle with the semisolid 
fecal mass in the center or merging of two or three wet 
feces with a large covered area on white blotting paper. 
Spasmolytic activity: The antispasmodic activity of the 
crude extract was investigated on isolated rabbit jeju-
num preparations by using previously described 
 Bangladesh J Pharmacol 2014; 9: 636-644 637 
 methods (Khan et al., 2012; Shah et al., 2014). The 
male/female rabbits (1-1.5 kg) of local breed were 
subjected to 12-16 hours starvation and sacrificed subse
-quent to cervical dislocation. The jejunum was 
dissected out and placed in Tyrode’s solution aerated 
with carbogen (95% O2 + 5% CO2) to remove the mesen-
teries. The jejunum was cut into 2 cm long tissue 
segments which were mounted in 10 mL tissue organ 
baths filled with Tyrode’s solution maintained at 37°C 
and continuously aerated with carbogen. A preload of 
1 g was applied to each tissue and was allowed to 
equilibrate for 30 min prior to the addition of any test 
material. The tissues were stabilized by repeated expo-
sure to sub-maximal concentration of acetylcholine 
(ACh; 0.3 µM). The preparations were presumed stable 
when three successive responses to acetylcholine were 
found to be identical. The isolated rabbit jejunum prepa-
rations exhibit spontaneous rhythmic contractions on 
which spasmolytic activity was tested directly without 
using any agonist (Mehmood et al., 2011). The crude 
extract was added to the tissue baths in cumulative 
manner and the obtained response was expressed as 
the percent change of spontaneous contractions in 
rabbit jejunum recorded prior to the exposure of the 
test material. The intestinal contractions were recorded 
via isotonic transducer 50-6360 (Harvard Apparatus, 
Holliston, MA, USA) attached to PowerLab (model: ML
-845), data acquisition system (AD Instruments; 
Sydney, Australia). 
The crude extract was subjected to further investiga-
tions to elucidate possible mechanism of its observed 
antispasmodic action through influence on high K+ (80 
mM)-induced contractions. The isolated tissue prepara-
tions on exposure to high K+ produce a sustained 
contraction through opening of voltage dependent Ca++ 
channels (VDCs) on which extract solution was applied 
in a cumulative manner to obtain concentration-depen-
dent inhibitory responses (Van Rossum, 1963). The 
observed relaxant effect of RCE on high K+-induced 
contraction on isolated rabbit jejunum preparations was 
quantified as percentage of the controlled contractile 
response and was speculated to be mediated through 
blockade of VDCs. 
To confirm Ca++ channel blocking effect, isolated rabbit 
jejunum preparations were allowed to stabilize in nor-
mal Tyrode’s solution whose composition was (mM): 
KCl (2.68), NaCl (136.9), MgCl2 (1.05), NaHCO3 (11.90), 
NaH2PO4 (0.42), CaCl2 (1.8) and glucose (5.55), which 
was subsequently replaced with Ca++-free Tyrode’s 
solution containing EDTA (0.1 mM) for 30 min in order 
to remove Ca++ from the tissue. The solution was 
further replaced with K+-rich and Ca++ -free Tyrode's 
solution, having the following composition (mM): KCl 
(50), NaCl (91.04), MgCl2 (1.05), NaHCO3 (11.90), 
NaH2PO4 (0.42), glucose (5.55) and EDTA (0.1). Follow-
ing an incubation period of 30 min, Ca++ was added in 
cumulative manner to obtain control calcium concen-
tration-response curves (CRCs). The experiment was 
repeated until the successive control CRCs of Ca++ were 
found to be super-imposable (usually after two cycles). 
The tissues were washed and allowed to be equilibrated 
in the presence of RCE for 1 hour followed by the 
construction of CRCs of Ca++ in the presence of various 
concentrations of RCE and standard drug verapamil 
and compared with the control curve. 
Smooth muscle contractions are produced either by the 
extracellular Ca++ influx or the intracellular Ca++ release 
from sarcoplasmic reticulum (SR), hence the effect of 
the extract was observed on intracellular Ca++ release 
from SR. High K+-induced contractions were recorded 
in the absence and presence of RCE, cyclopiazonic acid, 
a specific inhibitor of Ca++ ATPase in smooth muscle SR 
(Seidler et al., 1989) and verapamil possessing inhibi-
tory influence on both the extracellular Ca++ influx via 
VDCs and the intracellular Ca++ release form internal 
stores (Bolton, 1979). As, the high K+ is a known spas-
mogen to produce contraction by extracellular Ca++ 
influx through VDCs and  intracellular Ca++ release 
from SR (Brading, 1981). Thus, a substance, similar to 
cyclopiazonic acid, inhibiting partially the high K+-
induced contractions at low doses can be speculated to 
affect the release of Ca++ from SR.   
Acute toxicity test: Twenty four (male/female) BALB/c 
mice (20-25 g) were divided into 4 groups and each 
group was containing 6 animals. The group 1st, 2nd and 
3rd of mice served as test groups and were treated 
orally with the respective crude extract dose of 1,  3  
and 5 g/kg. The group 4th animals served as negative 
control and were treated with saline (10 mL/kg). The 
animals were deprived of food 12 hours prior to the 
test, while water remained freely available. The 
animals had been under strict observation for 8 hours 
for possible behavioral change and 24 hours monitoring 
for possible mortality. 
Statistical analysis: The data was expressed as mean ± 
standard error of the mean (s.e.m; n = number of 
experiments) and the median effective concentrations 
(EC50 values) with 95% confidence intervals (CI). One-
way ANOVA followed by Dunnett’s test was used for 
antidiarrheal activity experiments, while two-way 
ANOVA followed by Bonferroni’s post-test correction 
was used for comparison of concentration-response 
curves (CRCs) with the control and p<0.05 was 
considered significantly different. The CRCs were 
analyzed by non-linear regression using GraphPAD 
program (GraphPAD, San Diego, California, USA).  
 
Results 
In enteropooling assay, castor oil exhibited a substantial 
increase of fluid accumulation in mice with (Pi/Pm) × 
1,000 value of 152 ± 7.0, while saline as a negative 
control, exhibited 104 ± 5.1 (p<0.001). Crude excract of 
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 R. coriaria produced significant (p<0.001) reduction in 
castor oil-induced fluid accumulation at 100 and 300 
mg/kg with (Pi/Pm) × 1,000 values of 90 ± 2.9 and 69 ± 
5.2, respectively, similar to verapamil (65 ± 3.2) at a 
dose of 100 mg/kg. All (Pi/Pm) × 1,000 values are 
expressed as mean ± s.e.m, n=6 (Figure 1). 
When tested in mice against castor oil-induced diarr-
hea, the plant extract at a dose of 100 and 300 mg/kg 
reduced the total number of wet feces to 4.33 ± 1.51 and 
2.75 ± 2.64, (mean ± SEM, n=6), respectively when 
compared with saline (8.75 ± 2.32, n=6), while lopera-
mide administration (a positive control) reduced the 
number of wet feces to 1.17 ± 1.47, the detail has been 
given in Table I. 
The crude extract caused inhibition of spontaneous 
and high K+ (80 mM)-induced spastic contractions in 
isolated rabbit jejunum preparations with respective EC50 
values of 0.35 mg/mL (0.26-0.46 mg/mL; n = 5) and 
0.04 mg/mL (0.03-0.08 mg/mL; n=4) (Figure 2 and 
3A). Verapamil (standard Ca++ channel blocker) also 
relaxed the spontaneous and high K+ (80 mM)-
induced contractions with EC50 values of 0.78 mg/mL 
(0.52-1.23 mg/mL; n=4) and 0.08 mg/mL (0.04-0.16 
mg/mL; n=5) (Figure 2 and 3B).  
The Ca++ channel blocking activity was confirmed 
further when crude extract treatment of the isolated 
rabbit jejunum preparations resulted in rightward shift 
in the CRCs for Ca++with suppression (p<0.001) of the 
maximal response (100%) to a level of 63.7 ± 7.01% 
(n=7) and 38.5 ± 3.5% (n=6) at respective tissue bath 
concentration of 0.01 and 0.03 mg/mL (Figure 4A). 
Verapamil also produced a rightward shift in the CRCs 
of Ca++ and attenuated (p<0.001) the maximal response 
Figure 1: The dose-dependent inhibitory effect of the crude extract of Rhus coriaria (RCE) on castor oil-induced fluid accumulation 
in the small intestine of mice. Intestinal fluid accumulation is expressed as Pi/Pm × 1000 whereas Pi is the weight of the small intes-
tine and Pm is the weight (in g) of the mouse. The values are mean ± s.e.m., n=6. **p < 0.01 and ***p < 0.001 (Unpaired t-test or One
-way ANOVA followed by Dunnett’s test). 
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 to 62 ± 7.8% (n=5) and 22.2 ± 7.7% (n=4) at respective 
tissue bath concentrations of 0.01 and 0.03 µM (Figure 
4B).  
Pretreated rabbit jejunal preparations with RCE 
caused a partial inhibitory influence on high K+-
evoked spastic contractions at 0.03 and 0.1 mg/mL with 
respective values of 78.5 ± 2.7% (n=4) and 57.3 ± 2.6% 
(n=5) of  the control high K+-induced contractions taken 
as 100 %, similar to the effect of cyclopiazonic acid at 10 
µM (53.7 ± 2.8%, n=6) and verapamil at 0.03 µM (70.3 ± 
2.1%, n =4) and 0.1 µM (45.0 ± 2.2%, n=5) (Figure 5).  
Acute toxicity test: The RCE was found safe and did 
not exert any harmful effect in mice up to oral doses 
of 1, 3 and 5 g/kg.  
Table I. The protective effect of the crude extract of Rhus coriaria (RCE) on castor oil-induced diarrhea in mice. 
Treatment  Mean fecal 
output in 4 hours 
Mean No. of 
Wet feces in 4 hours 
% Protection 
Saline (10 mL/kg) plus castor oil (10 mL/kg) 10.0 ± 2.2  8.8 ± 2.3 12.5 
Loperamide (10) plus castor oil (10 mL/kg) 3.5 ± 2.6a 1.2 ± 1.5b 66.5 
RCE (100 mg/kg) plus castor oil (10 mL/kg) 8.8 ± 2.7 4.3 ± 1.5a 50.5 
RCE (300 mg/kg) plus castor oil (10 mL/kg) 6.4 ± 4.3 2.8 ± 2.6b 57.1 
Each group contained 6 animals. ap< 0.01 and bp< 0.001 compared with saline + castor oil treated group (One-way ANOVA followed by Dunnett’s 
test)  
Figure 2: Tracing showing the relaxant effects of the crude extract of Rhus coriaria (RCE) and verapamil on spontaneous contrac-
tions of isolated rabbit jejunum preparations 
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 Discussion 
The R. coriaria has been used to manage diarrhea and 
similar other hyperactive gut disorders in the 
traditional system of medicines (Usmanghani et al., 
1997). The crude extract R. coriaria of  was found to 
have beneficial effect on intestinal fluid contents and 
diarrhea as demonstrated by the observed protective 
effect against castor oil-induced fluid accumulation 
and diarrhea in mice. The castor oil-induced intestinal 
Figure 3: The spasmolytic effects of (A) the crude extract of Rhus coriaria (RCE) and (B) verapamil on spontaneous 
and high K+ (80 mM)-induced contractions in isolated rabbit jejunum preparations. Values shown represent mean ± 
s.e.m of 4-5 determinations 
Figure 4: The concentration response curves of Ca++ in the absence and presence of (A) the crude extract of Rhus coriaria (RCE) and 
(B) verapamil in isolated rabbit jejunum preparations. Values shown represent mean ± s.e.m of 4-7 determinations. ***p < 0.001 vs. 
control (Two-way ANOVA, followed by Bonferroni’s post-test correction) 
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 fluid accumulation or diarrhea is an outcome of the 
stimulant action of ricinoleic acid liberated during 
hydrolysis (Iwao and Terada, 1962), which influence 
electrolytes and water transport and hence produce 
violent contractions in the transverse and distal 
colon (Croci et al., 1997), hence, a substance capable 
to inhibit castor oil-induced intestinal fluid accumu-
lation or diarrhea would be able to demonstrate 
antidiarrheal effect.  
To explore the possible mode of action, the spasmo-
lytic potential of the extract was evaluated on spon-
taneously contracting isolated rabbit jejunum prepa-
rations (Mehmood et al., 2011; Janbaz et al., 2013; 
Khan et al., 2013). The increased free cytoplasmic 
Ca++ activates the contractile elements in smooth 
muscle preparations, including rabbit jejunum 
(Karaki and Wiess, 1983). The intracellular free Ca++ 
concentration is likely to be raised either rapid influx 
through VDCs or released from intracellular Ca++ 
storage sites located in sarcoplasmic reticulum. The 
spontaneous movements in the intestine are media-
ted through periodic depolarization and repolariza-
tion and the action potential appears due to rapid 
influx of Ca++ via VDCs at the climax of depolariza-
tion (Farre et al., 1991). The RCE exerted inhibitory 
effect on spontaneous movements in isolated rabbit 
jejunum preparations is likely to be mediated by 
interference either with in Ca++ influx through VDCs 
or Ca++ released from sarcoplasmic reticulum. The 
RCE exerted a concentration-dependent inhibitory 
response on application to high K+-induced spastic 
contractions. The exposure to high K+ (>30 mM) allows 
rapid influx of extracellular Ca++ and contraction of 
smooth muscle is achieved through opening of VDCs 
(Reynolds et al., 1984). The observed RCE inhibition of 
high K+-induced contraction is likely to be mediated 
through inhibition of Ca++ influx.  
The crude extract caused a rightward shift in the Ca++ 
Figure 5: Bar charts showing the inhibitory effects of (A) cyclopiazonic acid (CPA), (B) verapamil and (C) the crude extract of Rhus 
coriaria (RCE) and on K+ (80 mM)-induced contractions in isolated rabbit jejunum preparations. Values shown are mean ± s.e.m, 
n= 5-6; **p < 0.01 and ***p < 0.001 (Unpaired t-test or One-way ANOVA followed by Dunnett’s test) 
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 CRCs with suppression of the maximal response, 
similar to verapamil, a standard Ca++ channel blocker 
(Bolton, 1979), strongly suggests the presence of Ca++ 
antagonist(s) among the plant constituents. More-over, 
the opioid agonists are also known for their inhibitory 
influence on high K+-induced contractions (Mehmood 
and Gilani, 2010), hence, there is a possi-bility for the 
involvement of opioid receptor mediated responses in 
the relaxant effect of the plant extract, though further 
investigations are needed to state with confidence. 
Thus, the observed Ca++ antagonist effect on the part of 
plant extract may provide a scientific basis for the 
vernacular use of plant in diarrhea and abdominal 
spasm. The Ca++ antagonists are already known to be 
effective in the management of gut motility disorders, 
such as diarrhea and abdominal cramps (Brading, 
1981). 
On the basis of determined Ca++ antagonist-like activity 
of the plant extract, it was further tested for its effect on 
Ca++ release from intracellular stores. RCE inhibited the 
transient contractile peak of high K+-evoked contrac-
tions, obtained via release of Ca++ form intracellular 
stores, similar to the effect of cyclopiazonic acid (Seidler 
et al., 1989) and verapamil (Farre et al., 1991), which are 
also known for their inhibitory influence on Ca++-
ATPase in smooth muscle SR, indicating an inhibitory 
property of RCE on Ca++ release from SR. In addition, 
the plant materials are known to possess antibacterial 
activity (Abbas and Halkman, 2004) which could be an 
additional benefit for the management of infectious 
diarrhea. 
The presence of Ca++ antagonist-like constituent in R. 
coriaria besides being one of the possible antidiarrheal 
elements is well known for its antihypertensive activity 
(Hoffman, 2006). Hence, in case of hypertensive patient 
suffering from diarrhea, the administration of Rhus 
coriaria could be beneficial, while in normotensive 
patient with diarrhea, its intake might be harmful, 
particularly if it is well absorbed into systemic circula-
tion. However, the fact that the plant has not been 
traditionally used in cardiovascular disorders (Shabbir, 
2012), it is likely that either the plant has poor absorp-
tion or it contains some additional vasoconstrictor 
constituents, thus neutralizing the vasodilator effect 
due to the presence of Ca++ antagonist-like constituents. 
There are number of such examples where the plant 
such as turmeric known to possess Ca++ antagonist acti-
vity but no clinical use in cardiovascular disorders, 
probably due to the presence of vasoconstrictor consti-
tuents (Gilani et al., 2005).   
The present investigation on R. coriaria clearly demons-
trated its antisecretory, antidiarrheal and antispasmodic 
activities possibly mediated through Ca++ antagonist 
pathway, thus, providing a sound mechanistic back-
ground to validate its indigenous use in hyperkinetic gut 
disorders. 
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